Welcome to NGC. Skip directly to: Search Box, Navigation, Content.

Expert Commentary

Have Comments? E-mail them to us.


A Guideline for Palliative and End of Life Care

Karl Lorenz, MD, MSHS

The need to improve palliative care delivery is increasingly evident as the number of those who live in their later years with chronic disease-related impairment continues to rise, and the costs of late life care have become unsustainable. It is estimated that the last year of a person's life consumes around 30% of his or her lifetime Medicare expenditures (1). Fortunately, knowledge about how to deliver palliative care more effectively has also increased, and the American College of Physicians (ACP) has recently published Evidence-Based Interventions to Improve the Palliative Care of Pain, Dyspnea, and Depression at the End of Life. This guideline is based on a strong research synthesis, specific enough to guide some aspects of practice. The ACP's guideline:

One particularly important issue highlighted by the guideline is the relevance of palliative care to all patients living with serious chronic illness, including those living with cancer, advanced heart failure, chronic lung disease, or dementia. Relevance for palliative care isn't an issue of 'recognizable dying' because most patients living with serious impairment are at an elevated risk of dying, even though forecasting the timing of it is very imprecise. Palliative care relevance is related to the needs that patients and their families are struggling with. Those issues are related to disease progression and, while functional decline is more predictable with a disease like cancer, that is often not the case in other conditions (3).

Emphasis on 'chronic illness' rather than the dying also underscores the responsibility that both specialists and generalists have in improving palliative and end-of-life care. When they are seriously ill, patients often seek care from both generalists and specialists. Consequently, responsibility for symptom management and advance care planning may fall to a "system" rather than an individual provider. Because the ACP's guidelines adhere so closely to evidence, the recommendations provide guidance on symptomatic care and advance care planning that such patients and their families should expect to receive at a minimum. In addition, as a tool to aid implementation, the recommendations in these guidelines have already been embodied in quality indicators that can be used to evaluate current practice (4,5).

However, no guideline can cover all of any topic, and the ACP guideline is no exception. For example, because the evidence base supporting specific interventions for care giving, spiritual distress, or bereavement is limited, these topics are not addressed. Unfortunately, good clinicians can't ignore these issues because they are confronted by them daily and will continue to struggle with them. The ACP review also purposefully did not address with much specificity technical interventions for patients living with cancer (e.g., post-chemotherapy nausea and vomiting prophylaxis), areas which do have a large and specific literature base. Clinicians may be interested in guidance on all of these additional topics, because attention to them can have a big impact on cancer patients' quality of life. For these practitioners, supportive and palliative care standards such as those sponsored by the National Comprehensive Cancer Network, the Multinational Association of Supportive Care in Cancer, and similar leading organizations will provide more useful, specific standards (6,7).


Karl Lorenz, MD, MSHS
Los Angeles, CA


The views and opinions expressed are those of the author and do not necessarily state or reflect those of the National Guideline Clearinghouse (NGC), the Agency for Healthcare Research and Quality (AHRQ), or its contractor ECRI Institute.

Potential Financial Conflicts of Interest

Dr. Lorenz took part in the research synthesis used to develop the ACP's guideline "Evidence-Based Interventions to Improve the Palliative Care of Pain, Dyspnea, and Depression at the End of Life."

Dr. Lorenz is a palliative care staff physician in the VA Greater Los Angeles Healthcare systems and adjunct affiliate staff for RAND Corporation. He has also served on the NCQA Palliative care expert working group for PQRI quality indicators development process. He reports that Amgen Corporation has provided funding to RAND Health for development of the Cancer Quality-Assessing Symptoms, Side Effects, and Indicators of Supportive Treatment (ASSIST) Project.


  1. Hogan C, Lunney J, Gabel J, Lynn J. Medicare beneficiaries costs of care in the last year of life. Health Aff (Millwood). 2001:20:188-95.
  2. Qaseem A, Snow V, Shekelle P, Casey DE, Cross JT, Owens DK for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life. Ann Intern Med. 2008 Jan;148:141-46.
  3. Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA. 2003 May 14;289(18):2387-92.
  4. Lorenz KA, Rosenfeld KE, Wenger NS. ACOVE palliative and end of life quality indicators. J Am Geriatr Soc. 2007 Oct;55(S2):S318-26.
  5. Lorenz KA, Dy SM, Naiem A, Walling AM, Sanati H, Smith P, Shanman R, Roth C, Asch SM. Quality measures for supportive cancer care: the cancer quality-ASSIST (assessing symptoms, side effects, and indicators of supportive treatment) project. J Pain Symptom Manage. In Press.
  6. NCCN cancer treatment guidelines. Available at http://www.nccn.org/professionals/default.asp. Accessed on April 22, 2008.
  7. Multinational Association of Supportive Care in Cancer: study groups and resource centers. Available at http://www.mascc.org/content/6.html. Accessed May 22, 2008.